In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 272 for your search:
Drug:  thiotepa
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 50 and under
Sponsor: Other
Protocol IDs: MSGCC-9720, NCI-V98-1428
2.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MSGCC-9721, NCI-V98-1438
3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 50 and under
Sponsor: Other
Protocol IDs: CDR0000066400, MSGCC-9739, NCI-V98-1433, NCT00003398
4.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 4 to 70
Sponsor: Other
Protocol IDs: CDR0000066968, RP 98-15, RPCI-RP-9815, NCI-V99-1527, NCT00003816
5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no greater than 60
Sponsor: NCI
Protocol IDs: NU-93B1, NCI-T93-0058D, T93-0058
6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-BS01, EU-94005
7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: SCTN-BR9405, EU-95048, NCT00002755
8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Adult
Sponsor: NCI
Protocol IDs: SWOG-S9623, CLB-9640, E-S9623, NCT00002772, S9623
9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-75104
10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: DM95-047, P30CA016672, MDA-DM-95047, NCI-G96-1014, CDR0000065048, NCT00002836
11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 60
Sponsor: Other
Protocol IDs: CDR0000065151, FRE-FNCLCC-PEGASE03, EU-96032, NCT00002870
12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18-physiologic 60
Sponsor: NCI, Other
Protocol IDs: CDR0000065391, CCCWFU-95496, NCI-G97-1145, NCT00002942
13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor:
Protocol IDs: SCTN-BR9810, EU-98054, NCT00003680
14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to physiologic 65
Sponsor: NCI
Protocol IDs: CPMC-IRB-7608, CPMC-CAMP-014, NCI-G00-1890, NCT00008203
15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: NCI
Protocol IDs: CLB-8082, CALGB-8082
16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 70
Sponsor: NCI
Protocol IDs: CLB-8281, CALGB-8281
17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: premenopausal
Sponsor: NCI
Protocol IDs: EST-5181
18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-6181
19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NBCG-10
20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NBCG-11
21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8122
22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8215
23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-7676
24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: SEG-GU-83321, SEG-GU-83-321
25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-30782
1     
New Search